Cargando…

Untargeted plasma metabolomics and risk of colorectal cancer—an analysis nested within a large-scale prospective cohort

BACKGROUND: Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide, but if discovered at an early stage, the survival rate is high. The aim of this study was to identify novel markers predictive of future CRC risk using untargeted metabolomics. METHODS: This study included pros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vidman, Linda, Zheng, Rui, Bodén, Stina, Ribbenstedt, Anton, Gunter, Marc J., Palmqvist, Richard, Harlid, Sophia, Brunius, Carl, Van Guelpen, Bethany
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583301/ https://www.ncbi.nlm.nih.gov/pubmed/37849011 http://dx.doi.org/10.1186/s40170-023-00319-x

Ejemplares similares

Density of CD3(+) and CD8(+) Cells in the Microenvironment of Colorectal Cancer according to Prediagnostic Physical Activity
por: Renman, David, et al.
Publicado: (2021)

A two-tiered targeted proteomics approach to identify pre-diagnostic biomarkers of colorectal cancer risk
por: Harlid, Sophia, et al.
Publicado: (2021)

Plasma Concentrations of Gut Hormones Acyl Ghrelin and Peptide YY and Subsequent Risk of Colorectal Cancer and Molecular Tumor Subtypes
por: Bodén, Stina, et al.
Publicado: (2023)

Plasma ghrelin is probably not a useful biomarker for risk prediction or early detection of colorectal cancer
por: Sundkvist, Anneli, et al.
Publicado: (2019)

Targeted plasma proteomics identifies a novel, robust association between cornulin and Swedish moist snuff
por: Sundkvist, Anneli, et al.
Publicado: (2018)

The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples
por: Harlid, Sophia, et al.
Publicado: (2017)

Risk-Predictive and Diagnostic Biomarkers for Colorectal Cancer; a Systematic Review of Studies Using Pre-Diagnostic Blood Samples Collected in Prospective Cohorts and Screening Settings
por: Harlid, Sophia, et al.
Publicado: (2021)

A longitudinal study of prediagnostic metabolic biomarkers and the risk of molecular subtypes of colorectal cancer
por: Myte, Robin, et al.
Publicado: (2020)

An LC-QToF MS based method for untargeted metabolomics of human fecal samples
por: Cheng, Ken, et al.
Publicado: (2020)

Large-scale untargeted LC-MS metabolomics data correction using between-batch feature alignment and cluster-based within-batch signal intensity drift correction
por: Brunius, Carl, et al.
Publicado: (2016)

The inflammatory potential of diet in determining cancer risk; A prospective investigation of two dietary pattern scores
por: Bodén, Stina, et al.
Publicado: (2019)

An epigenome-wide analysis of sex hormone levels and DNA methylation in male blood samples
por: Harbs, Justin, et al.
Publicado: (2023)

Circulating levels of inflammatory markers and DNA methylation, an analysis of repeated samples from a population based cohort
por: Myte, Robin, et al.
Publicado: (2019)

Plasma miRNA can detect colorectal cancer, but how early?
por: Wikberg, Maria L., et al.
Publicado: (2018)

Untargeted Metabolomics Reveals Major Differences in the Plasma Metabolome between Colorectal Cancer and Colorectal Adenomas
por: Gumpenberger, Tanja, et al.
Publicado: (2021)

Investigation of circulating metabolites associated with breast cancer risk by untargeted metabolomics: a case–control study nested within the French E3N cohort
por: Jobard, Elodie, et al.
Publicado: (2021)

Prediagnostic Prescription Antibiotics Use and Survival in Patients with Colorectal Cancer: A Swedish National Register-Based Study
por: Lu, Sai San Moon, et al.
Publicado: (2023)

Comprehensive Peak Characterization (CPC) in Untargeted LC–MS Analysis
por: Pirttilä, Kristian, et al.
Publicado: (2022)

A Case Report of Switching from Specific Vendor-Based to R-Based Pipelines for Untargeted LC-MS Metabolomics
por: Fernández-Ochoa, Álvaro, et al.
Publicado: (2020)

Antibiotics Use and Subsequent Risk of Colorectal Cancer: A Swedish Nationwide Population-Based Study
por: Lu, Sai San Moon, et al.
Publicado: (2021)

Comparison of dried blood spot and plasma sampling for untargeted metabolomics
por: Tobin, Nicole H., et al.
Publicado: (2021)

Development, characterization and comparisons of targeted and non-targeted metabolomics methods
por: Ribbenstedt, Anton, et al.
Publicado: (2018)

Discovery of plasma biomarkers for colorectal cancer diagnosis via untargeted and targeted quantitative metabolomics
por: Wang, Maoqing, et al.
Publicado: (2022)

Potential Plasma Metabolite Biomarkers of Diabetic Nephropathy: Untargeted Metabolomics Study
por: Trifonova, Oxana P., et al.
Publicado: (2022)

Untargeted plasma metabolome identifies biomarkers in patients with extracranial arteriovenous malformations
por: Fan, Xueqiang, et al.
Publicado: (2023)

A comparison of high-throughput plasma NMR protocols for comparative untargeted metabolomics
por: Bliziotis, Nikolaos G., et al.
Publicado: (2020)

Preanalytical Pitfalls in Untargeted Plasma Nuclear Magnetic Resonance Metabolomics of Endocrine Hypertension
por: Bliziotis, Nikolaos G., et al.
Publicado: (2022)

Untargeted Metabolomic Characterization of Ovarian Tumors
por: Liu, Xiaona, et al.
Publicado: (2020)

Editorial: Advances and challenges in untargeted metabolomics
por: Wawrzyniak, Renata, et al.
Publicado: (2023)

Untargeted plasma and tissue metabolomics in rats with chronic kidney disease given AST-120
por: Velenosi, Thomas J., et al.
Publicado: (2016)

Inter-laboratory reproducibility of an untargeted metabolomics GC–MS assay for analysis of human plasma
por: Lin, Yanping, et al.
Publicado: (2020)

Untargeted metabolomics for uncovering plasma biological markers of wet age-related macular degeneration
por: Deng, Yanhui, et al.
Publicado: (2021)

Untargeted metabolomic and lipidomic analyses reveal lipid dysregulation in the plasma of acute leukemia patients
por: Arévalo, Cindy, et al.
Publicado: (2023)

New plasma preparation approach to enrich metabolome coverage in untargeted metabolomics: plasma protein bound hydrophobic metabolite release with proteinase K
por: Wawrzyniak, Renata, et al.
Publicado: (2018)

Plasma metabolites associated with type 2 diabetes in a Swedish population: a case–control study nested in a prospective cohort
por: Shi, Lin, et al.
Publicado: (2018)

Untargeted GC-MS-Based Metabolomics for Early Detection of Colorectal Cancer
por: Zhu, Guoxue, et al.
Publicado: (2021)

Untargeted Metabolomics To Ascertain Antibiotic Modes of Action
por: Vincent, Isabel M., et al.
Publicado: (2016)

Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics
por: Martín-Blázquez, Ariadna, et al.
Publicado: (2020)

Variable Selection in Untargeted Metabolomics and the Danger of Sparsity
por: Tinnevelt, Gerjen H., et al.
Publicado: (2020)

Current Practice in Untargeted Human Milk Metabolomics
por: Ten-Doménech, Isabel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d178nar69arkbu44l96veoojih